Osaic Holdings
WINT

Osaic Holdings’s Windtree Therapeutics WINT Stock Holding History

Osaic Holdings’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Hold
0
– – – 7634
2024
Q1 		– Hold
0
– – – 7420
2023
Q4 		– Hold
0
– – – 7281
2023
Q3 		– Hold
0
– – – 7377
2023
Q2 		– Hold
0
– – – 7445
2023
Q1 		– Sell
-1
Closed -$6.7K – 7470
2022
Q4 		$8K Hold
1
– – ﹤0.01% 6072
2022
Q3 		$11K Buy
+1
New +$17.9K ﹤0.01% 5987
2022
Q2 		– Hold
0
– – – 7170
2022
Q1 		– Hold
0
– – – 6513
2021
Q4 		– Hold
0
– – – 6795
2021
Q3 		– Hold
0
– – – 6552
2021
Q2 		– Hold
0
– – – 5839
2021
Q1 		– Hold
0
– – – 5798

Other funds holding WINT

TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings's WINT Position: Q2 2024 in Review

Osaic Holdings held its Windtree Therapeutics (WINT) position steady in Q2 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7634.

Osaic Holdings first reported a position in WINT in Q3 2022 and has held it in 2 quarters since. The position peaked at $11K in Q3 2022. 1 fund tracked by Wall St. Rank holds WINT as of Q2 2024.

  • Osaic Holdings held 0 shares of Windtree Therapeutics worth $0 as of Q2 2024.
  • Osaic Holdings left its Windtree Therapeutics share count unchanged in Q2 2024.
  • Windtree Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2024, its #7634 holding.
  • Osaic Holdings first reported a position in Windtree Therapeutics in Q3 2022 and has held it in 2 quarters since.
  • Osaic Holdings's Windtree Therapeutics position peaked at $11K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Windtree Therapeutics as of Q2 2024.

Based on Osaic Holdings's 13F filing for Q2 2024, filed 13 Aug 2024.